Shanghai Composite Falls 0.3% at Midday; Consumer and Pharma Stocks Rally

The divergence between the headline index and the pockets of strength is the story here: consumer, pharma and shipping names are drawing bids even as the broader tape softens, and a fifth straight limit-up in one consumer name signals speculative appetite concentrated in a narrow set of themes rather than broad risk-on. Decliners outnumbering advancers despite the modest index decline points to weakness beneath the surface, with turnover staying heavy. Whether that rotation into defensives and select consumer plays persists, or the breadth deterioration eventually drags the leaders down, is the open question to watch.